Study of SAB-176 in Healthy Adult Participants

Clinical trial NCT04850898 · COMPLETED

Trial details

NCT number: NCT04850898
Sponsor: SAb Biotherapeutics, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Influenza A H1N1

Start date: 2021-06-23
Primary completion: 2021-10-08
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.